BCL2 and melanoma: After treatment, excessive DNA damage in melanoma cells leads to an increase in the expression of pro‐apoptotic genes (Caspase‐3) and a decrease in the expression of DNA repair gene (PARP1) and anti‐apoptotic gene (Bcl‐2) to activate the apoptosis pathway.